Exyte, a specialist in the design and construction of high tech facilities, and Univercells Technologies, a provider of novel biomanufacturing technologies for economic and scalable viral production, are partnering for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.   The partnership is in response to the increased global demand for vaccines during the COVID-19 pandemic, which will require expedited delivery of large amounts of vaccine doses...